Vikram

Amar, a determined investigator, is tasked with a string of brutal killings. As he digs into the case, what seems like a straightforward hunt for a single killer quickly expands into a tangle of layers and false leads. Evidence points in conflicting directions, and loyalties blur as different groups press their own agendas. The investigation drags Amar into a dangerous game where mistakes could unleash a wider conflict among investigators, criminals, and powerful figures. The film keeps the focus on character choices and moral ambiguities, tightening the net around a mystery that refuses to stay contained. The result is a thriller that plays with perception as it tests trust.

Directed by Lokesh Kanagaraj, Vikram stars Kamal Haasan in a dual role with Fahadh Faasil and Vijay Sethupathi. Produced by Raaj Kamal Films International, the 2022 release is an original Tamil action thriller built around layered investigations. Its visuals, score and brisk pacing earned praise alongside the performances.

It grossed about 54.2 million worldwide against a budget of roughly 15.35 million, marking one of Tamil cinema's more profitable releases that year. Strong box office performance came from a star-studded cast, sharp set pieces, and scenes that resonated with a wide audience.

Vikram helped cement Lokesh Kanagaraj's status as a director who can orchestrate a large ensemble within a dense thriller. It sparked discussion about cross-film connections in Tamil cinema, signaling a universe fans welcomed. Performances by Kamal Haasan, Fahadh Faasil, and Vijay Sethupathi became talking points, with audiences citing memorable confrontations and a willingness to blend genre with political intrigue worldwide.

Critics praised its tightly wound plot and the balance of mystery with action, though some noted pacing dips. The film probes power and accountability, showing how institutions and people drift toward corruption while loyalties complicate justice. Haasan and Faasil deliver convincing performances that power the narrative.